DBX3:F:F-Xtrackers - MSCI EM Latin America Swap UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 33.645

Change

+0.03 (+0.07)%

Market Cap

N/A

Volume

2.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-05 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.27 (+1.02%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.43 (+0.87%)

USD 114.95B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 98.13B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 91.82B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.14 (+0.93%)

USD 54.47B
VUSA:F Vanguard Funds Public Limited ..

+0.66 (+0.66%)

USD 51.63B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.06 (+0.06%)

USD 51.63B
SXRZ:F iShares VII PLC - iShares Nikk..

+2.55 (+1.09%)

USD 50.58B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 40.89B
0ZC:F Zscaler Inc

+4.26 (+2.56%)

USD 37.92B

ETFs Containing DBX3:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -18.29% 7% C- 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -18.29% 7% C- 31% F
Trailing 12 Months  
Capital Gain -10.39% 9% A- 34% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -10.39% 10% F 34% F
Trailing 5 Years  
Capital Gain -22.67% 5% F 33% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -22.67% 5% F 33% F
Average Annual (5 Year Horizon)  
Capital Gain 4.96% 55% F 56% F
Dividend Return 4.96% 53% F 50% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 15.10% 41% F 77% C+
Risk Adjusted Return 32.87% 49% F 57% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.